المؤلفون: de Villiers M; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences North-West University, Private Bag X6001, Potchefstroom 2520, South Africa., Kotzé AF; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences North-West University, Private Bag X6001, Potchefstroom 2520, South Africa., du Plessis LH; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences North-West University, Private Bag X6001, Potchefstroom 2520, South Africa.

المصدر: Biomedical materials (Bristol, England) [Biomed Mater] 2024 Aug 19; Vol. 19 (5). Date of Electronic Publication: 2024 Aug 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Institute of Physics Pub Country of Publication: England NLM ID: 101285195 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-605X (Electronic) Linking ISSN: 17486041 NLM ISO Abbreviation: Biomed Mater Subsets: MEDLINE

مواضيع طبية MeSH: Bioprinting*/methods , Melanoma*/pathology , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Cell Survival*/drug effects , Drug Screening Assays, Antitumor* , Cell Culture Techniques, Three Dimensional*, Humans ; Cell Line, Tumor ; Cell Culture Techniques ; Printing, Three-Dimensional ; High-Throughput Screening Assays/methods ; Reproducibility of Results ; Tumor Microenvironment ; Spheroids, Cellular

المؤلفون: Pong KCC; Department of Biomedical Engineering, The Chinese University of Hong Kong, New Territories, Hong Kong, China.; BioArchitec Group Limited, Hong Kong, China., Lai YS; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China., Wong RCH; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China., Lee ACK; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China., Chow SCT; BioArchitec Group Limited, Hong Kong, China., Lam JCW; BioArchitec Group Limited, Hong Kong, China., Ho HP; Department of Biomedical Engineering, The Chinese University of Hong Kong, New Territories, Hong Kong, China., Wong CTT; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.

المصدر: Biosensors [Biosensors (Basel)] 2024 Aug 15; Vol. 14 (8). Date of Electronic Publication: 2024 Aug 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Pub Country of Publication: Switzerland NLM ID: 101609191 Publication Model: Electronic Cited Medium: Internet ISSN: 2079-6374 (Electronic) Linking ISSN: 20796374 NLM ISO Abbreviation: Biosensors (Basel) Subsets: MEDLINE

مواضيع طبية MeSH: Spheroids, Cellular* , High-Throughput Screening Assays*, Humans ; Drug Evaluation, Preclinical ; Cell Survival ; Drug Screening Assays, Antitumor ; Cell Line, Tumor ; Cell Culture Techniques

المؤلفون: Takahashi Y; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Morimura R; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Tsukamoto K; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan., Gomi S; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan., Yamada A; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan., Mizukami M; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan., Naito Y; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan., Irie S; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan., Nagayama S; Department of Colorectal Surgery, Gastroenterological Cancer Center, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan; Department of Surgery, Uji Tokushukai Medical Center, Kyoto 611-0041, Japan., Shinozaki E; Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Yamaguchi K; Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Fujita N; Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Kitano S; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan. Electronic address: shiro.kitano@toppan.co.jp., Katayama R; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan. Electronic address: ryohei.katayama@jfcr.or.jp., Matsusaki M; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan; Department of Applied Chemistry Graduate School of Engineering Osaka University, Osaka 565-0871, Japan. Electronic address: m-matsusaki@chem.eng.osaka-u.ac.jp.

المصدر: Acta biomaterialia [Acta Biomater] 2024 Jul 15; Vol. 183, pp. 111-129. Date of Electronic Publication: 2024 May 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7568 (Electronic) Linking ISSN: 17427061 NLM ISO Abbreviation: Acta Biomater Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Drug Screening Assays, Antitumor*/methods, Humans ; Cell Line, Tumor ; Stromal Cells/drug effects ; Stromal Cells/cytology ; Stromal Cells/metabolism ; Cell Culture Techniques, Three Dimensional/methods ; High-Throughput Screening Assays/methods ; Tumor Microenvironment/drug effects ; Human Umbilical Vein Endothelial Cells/metabolism ; Human Umbilical Vein Endothelial Cells/drug effects ; Female ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Fibroblasts/cytology ; Coculture Techniques

المؤلفون: Pishas KI; Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia., Cowley KJ; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia., Llaurado-Fernandez M; Division of Gynecology Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, V5Z 1M9, Canada.; Department of Clinical Research, BC Cancer, Vancouver, British Columbia, V5Z 4E6, Canada., Kim H; Division of Gynecology Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, V5Z 1M9, Canada.; Department of Clinical Research, BC Cancer, Vancouver, British Columbia, V5Z 4E6, Canada., Luu J; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia., Vary R; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia., Bowden NA; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.; Drug Repurposing and Medicines Research Program, Hunter Medical Research Institute, New Lambton, New South Wales, 2305, Australia., Campbell IG; Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia., Carey MS; Division of Gynecology Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, V5Z 1M9, Canada.; Department of Clinical Research, BC Cancer, Vancouver, British Columbia, V5Z 4E6, Canada., Simpson KJ; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia. kaylene.simpson@petermac.org.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia. kaylene.simpson@petermac.org.; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, Victoria, 3010, Australia. kaylene.simpson@petermac.org., Cheasley D; Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia.

المصدر: Scientific data [Sci Data] 2024 Sep 19; Vol. 11 (1), pp. 1024. Date of Electronic Publication: 2024 Sep 19.

نوع المنشور: Journal Article; Dataset

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101640192 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4463 (Electronic) Linking ISSN: 20524463 NLM ISO Abbreviation: Sci Data Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , High-Throughput Screening Assays* , Cystadenocarcinoma, Serous*/drug therapy , Cystadenocarcinoma, Serous*/pathology, Humans ; Female ; Cell Line, Tumor ; Drug Screening Assays, Antitumor ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Carcinoma, Ovarian Epithelial/drug therapy

المؤلفون: Zhou L; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., van Bree N; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Boutin L; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Ryu J; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Moussaud S; Chemical Biology Consortium Sweden (CBCS), Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Liu M; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Otrocka M; Chemical Biology Consortium Sweden (CBCS), Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Olsson M; Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden., Falk A; Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, Lund, Sweden.; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Wilhelm M; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.

المصدر: Neuro-oncology [Neuro Oncol] 2024 Sep 05; Vol. 26 (9), pp. 1685-1699.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cerebellar Neoplasms*/drug therapy , Cerebellar Neoplasms*/pathology , Cerebellar Neoplasms*/metabolism , High-Throughput Screening Assays* , Medulloblastoma*/drug therapy , Medulloblastoma*/pathology , Medulloblastoma*/metabolism , Neural Stem Cells*/metabolism , Neural Stem Cells*/drug effects , Neural Stem Cells*/pathology, Animals ; Humans ; Mice ; Antineoplastic Agents/pharmacology ; Cell Proliferation/drug effects ; Drug Screening Assays, Antitumor ; Hedgehog Proteins/metabolism ; Hedgehog Proteins/antagonists & inhibitors ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays

المؤلفون: Nayak S; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Kode Venkatadri Chowdary Campus), Vijayawada, Andhra Pradesh, India.; David Brown Children Eye Care Centre (DBCECC), L V Prasad Eye Institute (Kode Venkatadri Chowdary Campus), Vijayawada, Andhra Pradesh, India., Padhi TR; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, Odisha, India.; Miriam Hyman Children's Eye Care Centre (MHCECC), L V Prasad Eye Institute (MithuTulsi Chanrai Campus), Bhubaneswar, Odisha, India., Mettla AL; Allen Foster Community Eye Health Research Centre, Gullapalli Pratibha Rao International Centre for Advancement of Rural Eye care, L V Prasad Eye Institute, Hyderabad, Telangana, India.; School of Optometry and Vision Science, University of New South Wales, Sydney, Australia., Khanna RC; Allen Foster Community Eye Health Research Centre, Gullapalli Pratibha Rao International Centre for Advancement of Rural Eye care, L V Prasad Eye Institute, Hyderabad, Telangana, India. rohit@lvpei.org.; School of Optometry and Vision Science, University of New South Wales, Sydney, Australia. rohit@lvpei.org.; Brien Holden Eye Research Centre, L V Prasad Eye Institute, Banjara Hills, Hyderabad, Telangana, India. rohit@lvpei.org.; University of Rochester, School of Medicine and Dentistry, Rochester, NY, USA. rohit@lvpei.org.

المصدر: Eye (London, England) [Eye (Lond)] 2024 Aug; Vol. 38 (11), pp. 2216-2223. Date of Electronic Publication: 2024 Jul 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE

مواضيع طبية MeSH: Retinopathy of Prematurity*/diagnosis , Retinopathy of Prematurity*/epidemiology , Neonatal Screening*/methods, Humans ; Infant, Newborn ; Female ; Prospective Studies ; Risk Factors ; Male ; Prevalence ; Eye Abnormalities/diagnosis ; Eye Abnormalities/epidemiology ; Gestational Age ; Surveys and Questionnaires ; Ophthalmoscopy ; Vision Screening/methods ; Infant, Premature

المؤلفون: Kunkel MW; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Coussens NP; Molecular Pharmacology Laboratories, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Morris J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Taylor RC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Dexheimer TS; Molecular Pharmacology Laboratories, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Jones EM; Molecular Pharmacology Laboratories, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Teicher BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.

المصدر: Cancer research [Cancer Res] 2024 Aug 01; Vol. 84 (15), pp. 2403-2416.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Drug Screening Assays, Antitumor*/methods, Humans ; Cell Line, Tumor ; High-Throughput Screening Assays/methods ; Small Molecule Libraries/pharmacology ; Neoplasms/drug therapy ; Neoplasms/pathology ; Neoplasms/metabolism ; Cell Survival/drug effects

المؤلفون: Graham K; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Lienau P; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Bader B; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Prechtl S; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Naujoks J; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Lesche R; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Weiske J; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Kuehnlenz J; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Brzezinka K; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Potze L; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Zanconato F; Department of Molecular Medicine, University of Padua, Via Gabelli 63, 35121 Padua, Italy., Nicke B; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Montebaur A; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Bone W; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Golfier S; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Kaulfuss S; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Kopitz C; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Pilari S; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Steuber H; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Hayat S; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Kamburov A; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Steffen A; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Schlicker A; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Buchgraber P; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Braeuer N; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Font NA; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Heinrich T; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Kuhnke L; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Nowak-Reppel K; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Stresemann C; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Steigemann P; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Walter AO; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Blotta S; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Ocker M; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Lakner A; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., von Nussbaum F; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany., Mumberg D; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Eis K; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany., Piccolo S; Department of Molecular Medicine, University of Padua, Via Gabelli 63, 35121 Padua, Italy; IFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy., Lange M; Bayer AG, Pharmaceuticals, Research & Development, Muellerstr. 178, 13353 Berlin, Germany; Nuvisan ICB GmbH, Muellerstr. 178, 13353 Berlin, Germany. Electronic address: martin.lange@nuvisan.com.

المصدر: Cell chemical biology [Cell Chem Biol] 2024 Jul 18; Vol. 31 (7), pp. 1247-1263.e16. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE

مواضيع طبية MeSH: Transcription Factors*/metabolism , Transcription Factors*/antagonists & inhibitors , YAP-Signaling Proteins*/metabolism , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/chemical synthesis , Signal Transduction*/drug effects , Adaptor Proteins, Signal Transducing*/metabolism , Adaptor Proteins, Signal Transducing*/antagonists & inhibitors , Cell Proliferation*/drug effects , High-Throughput Screening Assays*, Humans ; Animals ; Mice ; rho GTP-Binding Proteins/metabolism ; rho GTP-Binding Proteins/antagonists & inhibitors ; Cell Line, Tumor ; Phosphoproteins/metabolism ; Phosphoproteins/antagonists & inhibitors ; Drug Screening Assays, Antitumor ; Alkyl and Aryl Transferases/antagonists & inhibitors ; Alkyl and Aryl Transferases/metabolism ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/pharmacology ; Drug Discovery ; Mice, Nude ; Acyltransferases/antagonists & inhibitors ; Acyltransferases/metabolism ; Phenotype ; Structure-Activity Relationship ; Transcriptional Coactivator with PDZ-Binding Motif Proteins

المؤلفون: Hollis RL; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK. Electronic address: robb.hollis@ed.ac.uk., Elliott R; Edinburgh Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Dawson JC; Edinburgh Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Ilenkovan N; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK; Cancer Research UK Scotland Institute, Glasgow, UK., Matthews RM; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Stillie LJ; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK; Cancer Research UK Scotland Institute, Glasgow, UK., Oswald AJ; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Kim H; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada., Llaurado Fernandez M; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada., Churchman M; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Porter JM; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Roxburgh P; Cancer Research UK Scotland Institute, Glasgow, UK; CRUK Scotland Centre, School of Cancer Sciences, Glasgow, UK., Unciti-Broceta A; Edinburgh Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Herrington CS; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Carey MS; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada., Carragher NO; Edinburgh Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Gourley C; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Jul; Vol. 186, pp. 42-52. Date of Electronic Publication: 2024 Apr 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/genetics , Pyridones*/pharmacology , Pyridones*/administration & dosage , Pyrimidinones*/pharmacology , Pyrimidinones*/administration & dosage , Drug Synergism* , High-Throughput Screening Assays* , Dasatinib*/pharmacology , Dasatinib*/administration & dosage , Cystadenocarcinoma, Serous*/drug therapy , Cystadenocarcinoma, Serous*/pathology , Cystadenocarcinoma, Serous*/genetics , Cystadenocarcinoma, Serous*/metabolism, Humans ; Female ; Cell Line, Tumor ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Neoplasm Grading ; Protein Kinase Inhibitors/pharmacology ; Disulfiram/pharmacology ; Drug Screening Assays, Antitumor

المؤلفون: Izquierdo G; Department of Pediatrics, Faculty of Medicine, University of Chile, Santiago 8820808, Chile.; Neonatal Intensive Care Unit, Hospital Barros Luco Trudeau, Santiago, Chile.; Centro de Investigación Clínica Avanzada (CICA), Hospital Exequiel González Cortés, Santiago, Chile., Guerra C; Neonatal Intensive Care Unit, Hospital Barros Luco Trudeau, Santiago, Chile., Reyes R; Neonatal Intensive Care Unit, Hospital Barros Luco Trudeau, Santiago, Chile., Araya L; Department of Pediatrics, Faculty of Medicine, University of Chile, Santiago 8820808, Chile.; Neonatal Intensive Care Unit, Hospital Barros Luco Trudeau, Santiago, Chile., Sepulveda B; Neonatal Intensive Care Unit, Hospital Barros Luco Trudeau, Santiago, Chile., Cabrera C; Neonatal Intensive Care Unit, Hospital Barros Luco Trudeau, Santiago, Chile., Medina P; Neonatal Intensive Care Unit, Hospital Barros Luco Trudeau, Santiago, Chile., Mardones E; Neonatal Intensive Care Unit, Hospital Barros Luco Trudeau, Santiago, Chile., Villavicencio L; Molecular Biology Laboratory, Hospital Lucio Córdova, Santiago, Chile., Montecinos L; Molecular Biology Laboratory, Hospital Lucio Córdova, Santiago, Chile., Tarque F; Molecular Biology Laboratory, Hospital Lucio Córdova, Santiago, Chile., Acevedo W; Molecular Biology Laboratory, Hospital Lucio Córdova, Santiago, Chile., Barraza M; Pharmacy Unit Santiago, Hospital Luis Calvo Mackenna, Santiago, Chile., Farfán M; Molecular Biology Laboratory, Hospital Luis Calvo Mackenna, Santiago, Chile., Mendez J; Molecular Biology Laboratory, Hospital Luis Calvo Mackenna, Santiago, Chile., Torres JP; Department of Pediatrics, Faculty of Medicine, University of Chile, Santiago 8820808, Chile.; Division of Pediatric Infectious Diseases, Hospital Luis Calvo Mackenna, Santiago, Chile.

المصدر: Viruses [Viruses] 2024 May 13; Vol. 16 (5). Date of Electronic Publication: 2024 May 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

مواضيع طبية MeSH: Saliva*/virology , Cytomegalovirus Infections*/diagnosis , Cytomegalovirus Infections*/congenital , Cytomegalovirus Infections*/epidemiology , Cytomegalovirus Infections*/virology , Cytomegalovirus*/genetics , Cytomegalovirus*/isolation & purification , Neonatal Screening*/methods , Developing Countries*, Humans ; Infant, Newborn ; Female ; Prospective Studies ; Male ; Molecular Diagnostic Techniques/methods ; Prevalence ; Mass Screening/methods ; Sensitivity and Specificity ; Pregnancy ; Risk Factors